A combination of low-dose systemic etretinate and topical calcipotriol/betamethasone dipropionate treatment for hyperkeratosis and itching in Olmsted syndrome associated with a TRPV3 mutation

Publication date: Available online 29 May 2017
Source:Journal of Dermatological Science
Author(s): Takuya Takeichi, Katsuhiko Tsukamoto, Yusuke Okuno, Daiei Kojima, Michihiro Kono, Yasushi Suga, Masashi Akiyama




http://ift.tt/2rjWTZa

http://ift.tt/2rBsR3M